1. Brady SN, Yu Y, Maggi Jr LB, Wber JD. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway. Mol Cell Biol. 2004 Nov; 24(21): 9327-38. DOI: 10.1128/MCB.24.21.9327-9338.2004 [ DOI] [ PubMed] 2. Katzung BG, Masters SB, Trevor AJ. Basic & Clinical Pharmacology. 12th ed. New York: McGrawHill. 2010. 3. Cornelis R, Caruso J, Crews H, Heumann K. Handbook of Elemental Speciation II – Species in the Environment, Food, Medicine and Occupational Health. John Wiley & Sons, Ltd. 2005; p: 100. DOI: 10.1002/0470856009 [ View at Publisher] [ DOI] 4. Colombo E, Marine JC, Danovi D, Falini B, Giuseppe Pelicci P. Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol. 2002 Jul; 4(7): 529-33. DOI: 10.1038/ncb814 [ DOI] [ PubMed] 5. Guidotti TL, McNamara J, Moses MS. The interpretation of trace element analysis in body fluids. Indian J Med Res. 2008 Oct; 128(4): 524-32. [ PubMed] 6. Wenninger JA, McEwen GN, eds. Canterbery RC. International cosmetic ingredient dictionary handbook. 7th ed. Washington D.C: The Cosmetic, Toiletry, and Fragrance Association. 1997. PP: 229-32. 7. Fleischauer AT, Arab L. Garlic and cancer: a critical review of the epidemiologic literature. J Nutr. 2001 Mar; 131(3s): 1032S-40S. DOI: 10.1093/jn/131.3.1032S [ DOI] [ PubMed] 8. Grimble RF. The effects of sulfur amino acid intake on immune function in humans. J Nutr. 2006 Jun; 136(6 Suppl): 1660S-1665S. DOI: 10.1093/jn/136.6.1660S [ DOI] [ PubMed] 9. Parcell S. Sulfur in human nutrition and applications in medicine. Altern Med Rev. 2002 Feb; 7(1): 22-44. [ PubMed] 10. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan V, Chen K, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med. 2009 Sep; 361(11): 1058-66. DOI: 10.1056/NEJMoa0903840 [ DOI] [ PubMed] 11. Bacher Ul, Haferlach T, Schoch C, Kern W, Schnittger S. Implications of NRAS mutations in AML: a study of 2502 patients. Blood. 2006 May; 107(10): 3847-53. DOI: 10.1182/blood-2005-08-3522 [ DOI] [ PubMed] 12. Verhaak RGW, Goudswaard CS, van Putten W, Bijl MA, Sanders MA, Hugens W, et al. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood. 2005 Dec; 106(12): 3747-54. DOI: 10.1182/blood-2005-05-2168 [ DOI] [ PubMed] 13. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood. 2000 Dec; 96(13): 4075-83. [ PubMed] 14. Byrd JC, Mrózek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002 Dec; 100(13): 4325-36. DOI: 10.1182/blood-2002-03-0772 [ DOI] [ PubMed] 15. Grisendi S, Pandolfi PP. NPM mutations in acute myelogenous leukemia. N Engl J Med. 2005 Jan; 352(3): 291-92. DOI: 10.1056/NEJMe048337 [ DOI] [ PubMed] 16. Jakubowski EM, Sidell FR, Evans RA, Carter MA, Keeler JR, McMonagle JD, et al. Quantification of thiodiglycol in human urine after an accidental sulfur mustard exposure. Toxicol Methods. 2000; 10(2): 143-50. DOI: 10.1080/10517230050083375 [ View at Publisher] [ DOI] 17. Sunday Abraham M, Iliyasu MO, Wilson OH, Augustine Oseloka I, Uduak Emmanuel U. Preventive activity of ascorbic acid on lead acetate induced cerebellar damaged in adult Wistar rats. Medical and Health Science Journal. 2012; 13(4): 99-104. DOI: 10.15208/mhsj.2012.68 [ View at Publisher] [ DOI] 18. Tachdjian G, Aboura A, Lapierre JM, Viguié F. Cytogenetic analysis from DNA by comparative genomic hybridization. Ann Genet. 2000 Jul-Dec; 43(3-4): 147-54. DOI: 10.1016/s0003-3995(00)01028-5 [ DOI] [ PubMed] 19. Fuller PJ, Chu S, Fikret S, Burger HG. Molecular pathogenesis of granulosa cell tumours. Mol Cell Endocrinol. 2002 May; 191(1): 89-96. DOI: 10.1016/s0303-7207(02)00059-x [ DOI] [ PubMed] 20. Singer G, Kurman RJ, Chang HW, Cho SKR, Shih IM. Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol. 2002 Apr; 160(4): 1223-28. DOI: 10.1016/s0002-9440(10)62549-7 [ DOI] [ PubMed] 21. Marcucci G, Maharry K, Wu YZ, Radmacher MD, Mrózek K, Margeson D, et al. IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. J Clin Oncol. 2010 May; 28(14): 2348-55. DOI: 10.1200/JCO.2009.27.3730 [ DOI] [ PubMed] 22. Francastel C, Schübeler D, Martin DI, Groudine M. Nuclear compartmentalization and gene activity. Nat Rev Mol Cell Biol. 2000 Nov; 1(2): 137-43. DOI: 10.1038/35040083 [ DOI] [ PubMed] 23. Bellinger DC. Very low lead exposures and children's neurodevelopment. Curr Opin Pediatr. 2008 Apr; 20(2): 172-77. DOI: 10.1097/MOP.0b013e3282f4f97b [ DOI] [ PubMed] 24. Clark AR. Placental transfer of lead and its effects on the newborn. Postgrad Med J. 1977 Nov; 53(625): 674-78. DOI: 10.1136/pgmj.53.625.674 [ DOI] [ PubMed] 25. Greben HA, Maree JP, Mnqanqeni S. Comparison between sucrose, ethanol and methanol as carbon and energy sources for biological sulphate reduction. Water Sci Technol. 2000; 41(12): 247-53. [ View at Publisher] [ DOI] 26. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med. 2005 Jan; 352(3): 254-66. DOI: 10.1056/NEJMoa041974 [ DOI] [ PubMed] |
